Summary of Study ST002413

This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench, https://www.metabolomicsworkbench.org, where it has been assigned Project ID PR001553. The data can be accessed directly via it's Project DOI: 10.21228/M8ZB01 This work is supported by NIH grant, U2C- DK119886.

See: https://www.metabolomicsworkbench.org/about/howtocite.php

This study contains a large results data set and is not available in the mwTab file. It is only available for download via FTP as data file(s) here.

Perform statistical analysis  |  Show all samples  |  Show named metabolites  |  Download named metabolite data  
Download mwTab file (text)   |  Download mwTab file(JSON)   |  Download data files (Contains raw data)
Study IDST002413
Study TitleIFN-inducible phospholipid levels govern endosomal antiviral immunity
Study SummaryUntargeted lipidomics of 3 cell lines at baseline with focus on phospholipids to understand the role of these lipids in endosomal antiviral immunity
Institute
University of Colorado Denver
LaboratoryAngelo D'Alessandro
Last NameHaines
First NameJulie
Address12801 E 17th Ave, Room 1303, Aurora, Colorado, 80045, USA
Emailjulie.haines@cuanschutz.edu
Phone3037243339
Submit Date2022-12-16
Num Groups3
Raw Data AvailableYes
Raw Data File Type(s)raw(Thermo)
Analysis Type DetailLC-MS
Release Date2023-01-04
Release Version1
Julie Haines Julie Haines
https://dx.doi.org/10.21228/M8ZB01
ftp://www.metabolomicsworkbench.org/Studies/ application/zip

Select appropriate tab below to view additional metadata details:


Project:

Project ID:PR001553
Project DOI:doi: 10.21228/M8ZB01
Project Title:IFN-inducible phospholipid levels govern endosomal antiviral immunity
Project Summary:The interferon-induced transmembrane proteins (IFITMs) are implicated in several biological processes including antiviral defense, but their modes of action remain debated. Here, taking advantage of pseudotyped viral entry assays and replicating viruses, we uncover the requirement of host co-factors for endosomal antiviral inhibition through high-throughput proteomics and lipidomics in cellular models of IFITM restriction. Unlike plasma membrane (PM)-localized IFITM restriction that targets infectious SARS-CoV2 and other PM-fusing viral envelopes, inhibition of endosomal viral entry depends on lysines within the conserved IFITM intracellular loop. These residues recruit phosphatydilinositol-3-phosphate (PIP3) that we show here to be required for endosomal IFITM activity. We identify PIP3 as an IFN-inducible phospholipid that acts as a rheostat for endosomal antiviral immunity as its expression levels correlated with the potency of endosomal IFITM restriction and exogenous PIP3 enhanced inhibition of endocytic viruses including the recent SARS-CoV2 Omicron variant. Together, our results identify PIP3 levels as a critical regulator of endosomal IFITM restriction linking it to the Pi3K/Akt/mTORC pathway and elucidate cell-compartment specific antiviral mechanisms, informing the development of broadly acting antiviral strategies.
Institute:University of Colorado Denver
Laboratory:Angelo D'Alessandro
Last Name:Haines
First Name:Julie
Address:12801 E 17th Ave, Room 1303, Aurora, Colorado, 80045, USA
Email:julie.haines@cuanschutz.edu
Phone:3037243339
  logo